Preliminary Efficacy and Safety Study of Oral Nepadutant in Infant With Colic Not Responding to Conventional Treatment
Status:
Withdrawn
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
This phase IIa study is designed as a multi-centre, single country, randomised, double-blind,
placebo controlled study in three parallel groups, with the aim to evaluate the efficacy and
safety of Nepadutant given at two oral doses once daily for seven days in comparison to
placebo in the treatment of infantile colic.